9987 Stock Overview
Primarily engages in the distribution of pharmaceuticals in Japan and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Suzuken Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥4,623.00 |
52 Week High | JP¥5,137.00 |
52 Week Low | JP¥3,647.00 |
Beta | 0.14 |
1 Month Change | -1.49% |
3 Month Change | 2.69% |
1 Year Change | 26.52% |
3 Year Change | 32.65% |
5 Year Change | -31.51% |
Change since IPO | 22.11% |
Recent News & Updates
Here's Why We Think Suzuken (TSE:9987) Is Well Worth Watching
Jun 12Shareholders Can Be Confident That Suzuken's (TSE:9987) Earnings Are High Quality
May 22Shareholder Returns
9987 | JP Healthcare | JP Market | |
---|---|---|---|
7D | -2.2% | 0.5% | 0.3% |
1Y | 26.5% | 0.8% | 17.5% |
Return vs Industry: 9987 exceeded the JP Healthcare industry which returned 1.4% over the past year.
Return vs Market: 9987 exceeded the JP Market which returned 19.8% over the past year.
Price Volatility
9987 volatility | |
---|---|
9987 Average Weekly Movement | 2.8% |
Healthcare Industry Average Movement | 3.5% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 7.5% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 9987 has not had significant price volatility in the past 3 months.
Volatility Over Time: 9987's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1932 | 13,429 | Shigeru Asano | www.suzuken.co.jp |
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies.
Suzuken Co., Ltd. Fundamentals Summary
9987 fundamental statistics | |
---|---|
Market cap | JP¥359.56b |
Earnings (TTM) | JP¥29.02b |
Revenue (TTM) | JP¥2.39t |
12.4x
P/E Ratio0.2x
P/S RatioIs 9987 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9987 income statement (TTM) | |
---|---|
Revenue | JP¥2.39t |
Cost of Revenue | JP¥2.20t |
Gross Profit | JP¥185.25b |
Other Expenses | JP¥156.23b |
Earnings | JP¥29.02b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 09, 2024
Earnings per share (EPS) | 373.72 |
Gross Margin | 7.76% |
Net Profit Margin | 1.22% |
Debt/Equity Ratio | 0% |
How did 9987 perform over the long term?
See historical performance and comparison